Please do not leave this page until complete. This can take a few moments.
More than 100 doctors and health care professionals from around Massachusetts signed onto an open letter urging state lawmakers to sink proposed bills that would open the door to allowing doctors to prescribe lethal doses of chemicals for terminally ill patients.
Bills that would legalize medical aid in dying — sometimes referred to as doctor-assisted suicide or death with dignity — were filed by Rep. Louis Kafka and Sen. William Brownsberger and are pending before the Joint Committee on Public Health with a reporting deadline of April 1.
"As physicians and healthcare professionals, we embrace a culture where ALL people receive appropriate medical care, regardless of economic state, ethnicity, age or disability," the physicians wrote in an open letter organized by the Massachusetts Alliance Against Doctor-Prescribed Suicide.
"We believe that the most vulnerable patients will suffer from legalization of lethal drugs by creation of a financial incentive for insurance companies and governments to save money by approving coverage of cheaper lethal drugs and denying lifesaving treatment, as has happened in states where assisted suicide is legal."
In each of the last at least five legislative sessions, bills to authorize medical aid in dying have been sent to study by the Joint Committee on Public Health, effectively spelling the end of the issue for each session.
Supporters of medical aid in dying, who had been optimistic in 2018 after the Massachusetts Medical Society voted to reconsider its longstanding opposition to medical aid in dying and instead adopt a position of neutral engagement, have pointed to a 2014 poll conducted by Purple Strategies that found 70 percent of Massachusetts voters support medical aid in dying as an option for terminally ill adults.
Massachusetts voters spoke directly to the issue in 2012 when they rejected a ballot question similar to the bills filed by Kafka and Brownsberger with 51 percent opposed and 49 percent in favor, a margin of 67,891 votes.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
1 Comments